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Secreted phospholipases A
2
 (sPLA
2
s) are pharmacologically 
important components of several animal venoms. Their neu-
rotoxic action on presynaptic neurons involves a reduction in 
endocytosis, leading to synaptic vesicle depletion. This results 
in suppression of the release of acetylcholine from neurons into 
the synaptic cleft, causing irreversible blockade of neurotransmis-
sion to the postsynaptic muscle cell.1 We have recently proposed 
a model of the molecular mechanism of action of the neurotoxic 
sPLA
2
 ammodytoxin A (AtxA).2 It is based on the experimental 
demonstration that the AtxA-induced reduction in endocytosis 
is a consequence of: (1) the specific intracellular interaction of 
AtxA with 14-3-3 proteins, which enables the toxin molecules to 
concentrate on the plasma membrane near the endocytic vesicles; 
and of (2) the PLA
2
 enzymatic activity of AtxA, which changes 
the shape and/or composition of the presynaptic membrane, thus 
inhibiting the activity of the endocytic protein amphiphysin.2 
The study was, however, performed in yeast, making the validity 
of the proposed model for mammalian cells a pivotal question.
The reduction of endocytosis in yeast was not observed with 
the catalytically inactive structural paralog of AtxA, ammodytin 
L (AtnL), although it was capable of binding to 14-3-3 proteins. 
A critical control in establishing the model in yeast was the dem-
onstration that the introduction, by genetic engineering, of PLA
2
 
The molecular mechanism of action of presynaptically neurotoxic secreted phospholipases A
2
 (sPLA
2
s) has not been 
fully elucidated. We have recently proposed a model to explain one of the hallmarks of their action – the reduction in 
endocytosis leading to synaptic vesicle depletion in nerve terminals. Our results speak strongly in favor of a mechanism 
in which both speciic protein-protein interactions and enzymatic activity of the neurotoxic sPLA
2
 ammodytoxin A (AtxA) 
are necessary for impairment of clathrin-dependent endocytosis in yeast cells. The reduction of endocytosis was strictly 
dependent on the enzymatic activity of sPLA
2
s expressed ectopically in our yeast model cells and was not observed with 
the catalytically inactive, non-neurotoxic AtxA-homolog, ammodytin L (AtnL). Here we conirm the validity of the model 
in mammalian cells also, by demonstrating that the enzymatically active mutant of AtnL, shown to inhibit endocytosis in 
yeast, acts as a presynaptically neurotoxic sPLA
2
 at the mammalian neuromuscular junction.
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enzymatic activity into AtnL generated a protein capable of reduc-
ing endocytosis in the same way as AtxA.2 This experiment pro-
vided the crucial proof for the indispensable role of PLA
2
 activity 
in the reduction of endocytosis by AtxA in yeast. In contrast to 
AtxA, AtnL is not neurotoxic in mammals and is a member of a 
large group of myotoxic snake venom sPLA
2
-homologs that have 
lost their enzymatic activity during evolution.3,4 While PLA
2
 
enzymatic activity is necessary for the presynaptic neurotoxicity 
of AtxA and of other sPLA
2
s,1 the myotoxic action of AtnL is 
based on a direct interaction with the cell membrane that is cal-
cium- and PLA
2
 activity-independent. This action leads to sus-
tained membrane damage and, eventually, cell lysis.4 Restoration 
of the calcium-dependent PLA
2
 activity in AtnL was achieved by 
introducing several residues from the calcium-binding network 
of AtxA. The enzymatically active mutant thus produced—AtnL 
(H28Y/L31W/N33G/S49D), abbreviated as LW—displayed 
several important characteristics typical of the neurotoxic AtxA: 
the enzymatic activity-dependent membrane-damaging activity, 
a higher cytotoxicity than that of AtnL in cell culture in vitro 
and, importantly, a significant increase in lethal potency in vivo.3 
The LD
50
 of the LW mutant in mice (2.2 mg/kg), although still 
approximately 100-fold higher than that of AtxA, was at least 
5-fold lower than that of AtnL (> 10 mg/kg). This offered the 
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had only a minor inhibitory effect on the twitch tension of a 
partly paralyzed NM preparation (data not shown). In experi-
ments performed in standard Krebs solution with 2.5 mM Ca2+, 
in which the majority of motor end-plates within the NM prep-
aration are sensitive to neuronal stimulation, AtxA inhibited 
muscle contractions in a manner consistent with our previous 
results.7 However, muscle contraction in standard Krebs solu-
tion was not affected by the addition of AtnL, at least not for 
up to 90 min, in the case of either indirect (Fig. 1C) or direct 
(Fig. 1D) stimulation of the muscle. This indicates that AtnL 
had no effect on acetylcholine release from the presynaptic neu-
rons or on the functionality of the postsynaptic muscle cell. 
Furthermore, addition of a very potent presynaptically neuro-
toxic sPLA
2
, taipoxin, to an NM preparation pre-treated with 
AtnL, triggered the characteristic triphasic change of muscle 
contractility, demonstrating that this preparation retained the 
ability to respond to neurotoxic sPLA
2
s (data not shown). These 
results show clearly that, by switching on calcium-binding and 
thus the PLA
2
 activity of AtnL, by replacing amino acid resi-
dues at four positions,3 this presynaptically inactive protein has 
been converted into a presynaptically active sPLA
2
 in mamma-
lian cells.
possibility that, with this acquired enzymatic activity, the LW 
mutant has also acquired the ability to act as a presynaptically 
neurotoxic sPLA
2
. The fact that the LW mutant and AtxA, 
but not AtnL, reduced endocytosis in the yeast model further 
strengthened such an explanation. To test the hypothesis that 
the mutations in AtnL that endowed it with PLA
2
 activity and 
the ability to impair endocytosis in yeast would also render it 
neurotoxic for mammals, we determined the effect of recom-
binant AtnL and its LW mutant on an isolated mouse phrenic 
nerve-hemidiaphragm preparation.
A hallmark of the action of presynaptically neurotoxic 
sPLA
2
s, including AtxA (Fig. 1A), is a triphasic effect on indi-
rectly elicited muscle twitch tension of partially paralyzed neu-
romuscular (NM) preparations.5,6 The modulation of twitch 
tension induced by the LW mutant conformed to the charac-
teristic triphasic action of presynaptically neurotoxic sPLA
2
s—
a short initial depression of muscle contraction followed by a 
transient increase in twitch tension and, third, a progressive 
decline in muscle contractility within 10 min after the appli-
cation of the mutant (Fig. 1B). The triphasic effect occurred 
almost 10-fold faster than in the case of AtxA. In contrast, 
recombinant AtnL did not trigger the triphasic response and 
Figure 1. AtxA and the LW mutant, but not the enzymatically inactive AtnL, display the triphasic modulation of twitch tension characteristic of pre-
synaptically neurotoxic sPLA
2
s. The efects of recombinant AtxA (10 μg/ml; 0.725 μM), the LW mutant (6 μg/ml; 0.430 μM) and AtnL (6 μg/ml; 0.433 
μM) on muscle twitch tension were determined at 37°C. (A and B) The NM preparation was partially paralyzed by a low Ca2+ concentration (0.38–0.50 
mM) Krebs solution and stimulated indirectly. Note that, upon addition of LW, the triphasic muscle twitch response occurred within 10 min (B). (C and 
D) The NM preparation was stimulated indirectly (C) or directly (D) in standard Krebs solution containing 2.5 mM Ca2+ as described in materials and 
methods. Note that AtxA, but not AtnL (C), inhibited muscle contractions. Proteins were added to the bath at time 0. Twitch tension is expressed as a 
percentage of the control value. The number of repeats of experiments is shown in brackets. Each point on the diagrams represents the mean ± SE. 
Standard errors are indicated by bars unless smaller than symbols.
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twitches were recorded on a Grass polygraph model 79 (Grass 
Instruments). In order to reveal the triphasic effect of recom-
binant proteins on NM transmission, in some experiments the 
preparation was partially paralyzed (to 15–20% of control) by 
reducing the concentration of Ca2+ to 0.38–0.50 mM and allow-
ing the tissues to equilibrate for 30–45 min. In these experi-
ments only a reduced number of motor end-plates were sensitive 
to stimulation. Recombinant proteins were added to the tissue 
bath and changes in the amplitude of twitch tension responses 
were followed continuously. The functionality of the muscle in 
the preparation at the end of the recordings was checked directly 
by acetylcholine stimulation or indirectly by 2.5 mM Ca2+ 
stimulation.
In experiments with directly-evoked twitches the preparation 
was set up as described for the phrenic nerve-hemidiaphragm 
for recording neurally-evoked twitches. In addition, one end of 
a bipolar stimulating electrode was sutured into the diaphragm 
muscle near the costal margin and the other one was attached 
to the base of the hemidiaphragm. The directly-evoked twitches 
were recorded by supramaximal voltage stimulation (50 V) at 
a frequency of 0.2 Hz and 2 ms duration. To eliminate NM 
transmission in the preparation, d-tubocurarine (10 μM), an 
antagonist of the nicotinic acetylcholine receptors, was added 
into the organ bath 5 min prior to the beginning of direct stimu-
lation. Positive controls for the neurotoxic triphasic effect were 
performed by adding taipoxin (0.5–1 μg/ml) after reducing the 
concentration of Ca2+ in order to partially paralyze the NM 
preparation as described above.
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The progressive decline of NM activity, along with other 
characteristic morphological changes induced by presynapti-
cally neurotoxic sPLA
2
s at the NM junction (i.e., appearance of 
omega-shaped invaginations in the plasma membrane and synap-
tic vesicle depletion), has been ascribed to an irreversible blockade 
of synaptic vesicle retrieval from the plasma membrane.1,7,8 This 
parallels the impairment of the endocytic machinery observed 
on expression of AtxA and LW in yeast cells.2 To summarize, 
the reduction in endocytosis previously observed in yeast cells, 
coupled with the neurotoxic action at the mouse NM junction by 
AtxA and the enzymatically active mutant of AtnL, but not by 
AtnL itself, confirm that the proposed model of sPLA
2
 toxicity 
in yeast is applicable to the molecular mechanism of action of 
neurotoxic sPLA
2
s in mammals.
Materials and Methods
Recombinant proteins and chemicals. Recombinant AtxA, 
AtnL and its quadruple H28Y/L31V/N33G/S49D mutant LW 
were prepared by in vitro refolding following expression in E. 
coli as described.3,9 All other chemicals were from Sigma Aldrich 
or Gibco Life Technologies.
Neuromuscular activity. Adult male BALB/c mice (20–
25 g) were maintained and humanely killed according to the 
Guiding Principles in the Use of Animals in Toxicology (Society 
of Toxicology, 1999, Guidelines are available at www.toxicol-
ogy.org) and the Animals (Scientific Procedures) Act 1986. 
Hemidiaphragms and accompanying phrenic nerves were dis-
sected and placed into 10 ml tissue baths containing Krebs solu-
tion (118.4 mM NaCl, 4.7 mM KCl, 25 mM NaHCO
3
, 1.2 mM 
KH
2
PO
4
, 1.4 mM MgSO
4
 and 2.5 mM CaCl
2
), maintained at 
37°C and oxygenated with a mixture 95% O
2
 and 5% CO
2
. 
Muscle contractions were evoked indirectly or directly. In the 
case of indirect neurally-evoked twitches, the attached phrenic 
nerve was stimulated at a frequency of 0.2 Hz with rectan-
gular pulses of 0.2 ms duration and a supramaximal voltage 
(< 15 V) from a Grass force displacement transducer. Muscle 
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